Get involved in the discussion! Click here to comment on this story
Clariant has signed an agreement with respect to the sale of its Healthcare Packaging business to a newly-formed affiliate of Arsenal Capital Partners. The total consideration of the sale amounts to approximately CHF 308 million payable at closing, which is expected in Q4 2019. The total consideration is equivalent to 13.2 times adjusted FY2018 EBITDA. The closing of the transaction is subject to customary conditions and approvals.
Clariant’s Healthcare Packaging business offers products used to protect pharmaceutical products from moisture and oxygen. This includes customizable, high-quality drop-in products (canisters and packets), Integrated Desiccant Systems and specially designed plastic bottles containing oxygen barrier materials. In 2018, the Healthcare Packaging business generated sales of around CHF 135 million. The business has manufacturing facilities in the USA, France, China and India and employs around 600 employees.
By Mary Page Bailey
Source: Chemical Engineering
LinkedIn Twitter FacebookUS-based leading speciality chemicals firm Gabriel Performance Products has acquired a selected portfolio of alkyd resins from Deltech Resin. Terms of the transaction were not disclosed. The acquisition […]
LinkedIn Twitter FacebookFrance’s Air Liquide is putting its German unit Schuelke up for sale in a deal worth up to 1 billion euros ($1.1 billion) as it seeks to streamline […]
LinkedIn Twitter FacebookLonza Chief Executive Marc Funk is leaving the Swiss chemicals company after less a year in the job, it said on Tuesday, citing personal reasons. Funk, who has […]